Fundraising support for childhood cancer research at the BC Cancer Agency enables researchers to conduct the Intra-Tumoural Heterogeneity Subproject, a study of important clinical significance to the overall MAGIC (Medulloblastoma Advanced Genomics International Consortium) project. The MAGIC project began with the genomic analysis of 1,000 pediatric medulloblastoma samples, representing the four currently known sub-types of the disease. By stratifying and targeting pediatric medulloblastoma through genomics, this international collaboration will result in better treatment solutions for medulloblastoma patients to improve and sustain their quality of life.